331800223-6-17-2026-18-AS-APEZ-DV7P8U-20260619110608

Community Care Licensing

COMPLAINT INVESTIGATION REPORT

Facility Number: 331800223
Report Date: 06/17/2026
Date Signed: 06/17/2026 02:51:05 PM

Unsubstantiated

STATE OF CALIFORNIA - HEALTH AND HUMAN SERVICES AGENCY

COMPLAINT INVESTIGATION REPORT

CALIFORNIA DEPARTMENT OF SOCIAL SERVICES
COMMUNITY CARE LICENSING DIVISION
RIVERSIDE ASC, 1650 SPRUCE ST STE 200 MS29-27
RIVERSIDE, CA 92507

This is an official report of an unannounced visit/investigation of a complaint received in our office on
09/02/2025 and conducted by Evaluator Abdoulaye Zerbo

COMPLAINT CONTROL NUMBER: 18-AS-20250902101154

FACILITY NAME:	YORKSHIRE VILLAGE		FACILITY NUMBER:	331800223
ADMINISTRATOR:	TERESA MAPILIS		FACILITY TYPE:	740
ADDRESS:	26933 CORNELL ST		TELEPHONE:	(951) 658-1068
CITY:	HEMET	STATE: CA	ZIP CODE:	92544
CAPACITY:	100	CENSUS: 90	DATE:	06/17/2026
		UNANNOUNCED	TIME BEGAN:	02:00 PM
MET WITH:	Nicole Kalacas		TIME COMPLETED:	03:10 PM

ALLEGATION(S):

1
2
3
4
5
6
7
8
9

Staff did not provide proper medication assistance to resident in care

INVESTIGATION FINDINGS:

1
2
3
4
5
6
7
8
9
10
11
12
13

Licensing Program Analyst (LPA) Abdoulaye Zerbo conducted an unannounced subsequent visit to the facility to deliver findings for the above allegation. LPA was greeted and granted entrance by Business Office Manager Nicole Kalacas. LPA identified himself and discussed the purpose of the visit.
It was alleged that staff did not provide proper medication assistance to resident in care. Resident 1 (R1) reported that during the previous year (2025), they believed they were receiving a lower dose of their psychotropic medication than prescribed and that their eye medication had not been administered correctly. However, R1 was not able to provide specific dates, or confirm which staff members were involved. LPA conducted staff interviews and the information obtained revealed that medications were administered as prescribed. LPA reviewed medication records, MARs, to corroborate the resident’s recollection of receiving incorrect dosages but did not find any discrepancies with the records. LPA could not corroborate the information with the confidential witness because no phone number was provided.

Unsubstantiated

Estimated Days of Completion:

SUPERVISORS NAME: Anthony Perez
LICENSING EVALUATOR NAME: Abdoulaye Zerbo
LICENSING EVALUATOR SIGNATURE:	DATE: 06/17/2026

I acknowledge receipt of this form and understand my licensing appeal rights as explained and received.

FACILITY REPRESENTATIVE SIGNATURE:

DATE: 06/17/2026

This report must be available at Child Care and Group Home facilities for public review for 3 years.

LIC9099 (FAS) - (06/04)

Page: 1 of 2

Control Number 18-AS-20250902101154

STATE OF CALIFORNIA - HEALTH AND HUMAN SERVICES AGENCY

COMPLAINT INVESTIGATION REPORT (Cont)

CALIFORNIA DEPARTMENT OF SOCIAL SERVICES
COMMUNITY CARE LICENSING DIVISION
RIVERSIDE ASC, 1650 SPRUCE ST STE 200 MS29-27
RIVERSIDE, CA 92507

FACILITY NAME: YORKSHIRE VILLAGE	FACILITY NUMBER: 331800223
	VISIT DATE: 06/17/2026

NARRATIVE

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32

LPA also called R1’s physician to verify R1’s statement but was unsuccessful. Additional interviews were conducted and the information obtained revealed that Staff reported that the only medication- related concern they recall involving R1 occurred when R1 was prescribed an antibiotic eye drop. Staff stated that when they informed R1 about the new medication and read the prescription label to them, R1 declined to take it, stating they were allergic to sulfates. Staff reported that they immediately notified the prescribing provider of R1’s allergy concern and requested the medication to be discontinued. Staff stated that the medication was discontinued within two days and confirmed that no doses were administered during that time. A review of R1's chart confirmed statement given by facility’s staff.
Regarding R1’s psychotropic medication (M1), staff reported that R1 has always been prescribed 3 mg at bedtime, administered as one whole tablet, and not as a partial dose. LPA reviewed R1’s MAR and confirmed that M1 was dispensed at a consistent dosage of 3 mg. LPA also reviewed pictures provided by R1 and confirmed that pills were not cut.

Based on the information obtained, the allegation is UNSUBSTANTIATED. A finding that the complaint is UNSUBSTANTIATED means the allegation may have happened or is valid, but there is not a preponderance of the evidence to prove that the alleged violation occurred.

An exit interview was conducted and a copy of this report was provided to Business Office Manager Nicole Kalacas.

SUPERVISORS NAME: Anthony Perez
LICENSING EVALUATOR NAME: Abdoulaye Zerbo
LICENSING EVALUATOR SIGNATURE:	DATE: 06/17/2026

I acknowledge receipt of this form and understand my licensing appeal rights as explained and received.

FACILITY REPRESENTATIVE SIGNATURE:

DATE: 06/17/2026

LIC9099 (FAS) - (06/04)

Page: 2 of 2